ASO Author Reflections: Access to Care and Screening Inequities for Patients At Risk for Hepatocellular Carcinoma.
作者信息
Kronenfeld Joshua P, Goel Neha
机构信息
Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.
出版信息
Ann Surg Oncol. 2021 Apr;28(4):1937-1938. doi: 10.1245/s10434-020-09172-4. Epub 2020 Sep 24.
Abstract
摘要
相似文献
1
ASO Author Reflections: Access to Care and Screening Inequities for Patients At Risk for Hepatocellular Carcinoma.美国骨科学会作者反思：肝细胞癌高危患者的医疗服务可及性与筛查不平等问题
Ann Surg Oncol. 2021 Apr;28(4):1937-1938. doi: 10.1245/s10434-020-09172-4. Epub 2020 Sep 24.
2
ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma.ASO作者反思：膜联蛋白A3作为肝细胞癌的潜在生物标志物
Ann Surg Oncol. 2019 Dec;26(Suppl 3):529-530. doi: 10.1245/s10434-018-6933-4. Epub 2018 Dec 5.
3
ASO Author Reflections: Association of County-level Upward Economic Mobility with Stage at Diagnosis and Receipt of Curative-Intent Treatment Among Patients with Hepatocellular Carcinoma.ASO作者反思：县级向上经济流动性与肝细胞癌患者诊断分期及接受根治性治疗之间的关联
Ann Surg Oncol. 2022 Aug;29(8):5186-5187. doi: 10.1245/s10434-022-11750-7. Epub 2022 Apr 13.
4
[Towards early screening and treatment of hepatocellular carcinoma cirrhosis?].[迈向肝细胞癌肝硬化的早期筛查与治疗？]
Gastroenterol Clin Biol. 2002 Jun-Jul;26(6-7):559-60.
5
Hepatocellular carcinoma.肝细胞癌
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):74-7. doi: 10.1054/bjoc.2001.1769.
6
[Synopsis: Diagnosis and treatment of hepatocellular carcinoma in patients with cirrhosis].[综述：肝硬化患者肝细胞癌的诊断与治疗]
Gastroenterol Clin Biol. 2002 Jan;26(1):73-7.
7
[Strengthening to diagnosis and treatment of hepatocellular carcinoma].[加强肝细胞癌的诊断与治疗]
Zhonghua Yi Xue Za Zhi. 2007 Aug 14;87(30):2089-91.
8
Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges.拉丁美洲的肝细胞癌：诊断和治疗挑战。
World J Gastroenterol. 2018 Oct 7;24(37):4224-4229. doi: 10.3748/wjg.v24.i37.4224.
9
Primary hepatocellular carcinoma: early diagnosis and importance of screening.原发性肝细胞癌：早期诊断及筛查的重要性
N Z Med J. 1995 May 10;108(999):175-6.
10
Endoscopic diagnosis and therapy of hepatocellular carcinoma.肝细胞癌的内镜诊断与治疗
Endoscopy. 1993 Jan;25(1):126-30. doi: 10.1055/s-2007-1010270.
引用本文的文献
1
An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma.肝细胞癌筛查、治疗及预后的个体和背景水平差异分析
J Hepatocell Carcinoma. 2021 Sep 28;8:1209-1219. doi: 10.2147/JHC.S284430. eCollection 2021.
2
Surgical oncology operative experience at a high-volume safety-net hospital during the COVID-19 pandemic.在 COVID-19 大流行期间，高容量安全网医院的外科肿瘤手术经验。
J Surg Oncol. 2021 Dec;124(7):983-988. doi: 10.1002/jso.26616. Epub 2021 Jul 22.
3
Overcoming Disparities in Cancer: A Need for Meaningful Reform for Hispanic and Latino Cancer Survivors.克服癌症差异：西班牙裔和拉丁裔癌症幸存者需要有意义的改革。
Oncologist. 2021 Jun;26(6):443-452. doi: 10.1002/onco.13729. Epub 2021 Mar 10.
本文引用的文献
1
Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study.肝细胞癌诊断时的表现差异：一项美国安全网合作研究。
Ann Surg Oncol. 2021 Apr;28(4):1929-1936. doi: 10.1245/s10434-020-09156-4. Epub 2020 Sep 25.
2
Hepatocellular carcinoma: a review.肝细胞癌：综述
J Hepatocell Carcinoma. 2016 Oct 5;3:41-53. doi: 10.2147/JHC.S61146. eCollection 2016.
3
Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.商业保险覆盖的非肝硬化慢性乙型肝炎患者的肝细胞癌监测率
J Viral Hepat. 2015 Sep;22(9):727-36. doi: 10.1111/jvh.12381. Epub 2015 Jan 12.
4
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.肝细胞癌综述：当前的治疗方法与循证医学
World J Gastroenterol. 2014 Apr 21;20(15):4115-27. doi: 10.3748/wjg.v20.i15.4115.
Zotero 插件